| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,051,000
|
871,000
|
754,000
|
842,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
1,051,000
|
871,000
|
754,000
|
842,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 568,000 | 967,000 | 502,000 | 500,000 |
|
Non Recurring |
-
| 492,000 |
-
|
-
|
|
Others | 196,000 | 185,000 | 181,000 | 163,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
287,000
|
(775,000)
|
70,000
|
179,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| (2,000) | (1,000) |
-
|
|
Earnings Before Interest And Taxes | 287,000 | (775,000) | 70,000 | 179,000 |
|
Interest Expense | 31,000 | 31,000 | 32,000 | 33,000 |
|
Income Before Tax | 256,000 | (806,000) | 38,000 | 146,000 |
|
Income Tax Expense | 48,000 | (13,000) | 10,000 | 36,000 |
|
Minority Interest | (4,000) | (4,000) |
-
| (2,000) |
|
|
|
Net Income From Continuing Ops | 208,000 | (800,000) | 26,000 | 124,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| (1,000) |
-
| 1,000 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
219,000
|
(805,000)
|
26,000
|
108,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
219,000
|
(805,000)
|
26,000
|
108,000
|
|
0.40(0.95%) 1:12PM EDT - Nasdaq Real Time Price